vimarsana.com
Home
Live Updates
Akero Shares Slide 68% on Study Miss; 89bio Shares Feel Fall
Akero Shares Slide 68% on Study Miss; 89bio Shares Feel Fall
Akero Shares Slide 68% on Study Miss; 89bio Shares Feel Fallout
By Colin Kellaher Akero Therapeutics shares lost two-thirds of their value and fell to a 52-week low on Tuesday after the biotechnology company said a Phase...
Related Keywords
United States ,
Americans ,
Andrew Cheng ,
Colin Kellaher ,
Thomas Smith ,
Nat Charoensook ,
,
South San Francisco ,
Executive Andrew Cheng ,
Article Normal ,
Biotechnology Services ,
Pharmaceuticals ,
Scientific Research Services ,
Healthcare Life Sciences ,
Business Consumer Services ,
Biopharmaceuticals ,
Medical Research Services ,
Healthcare Support Services ,
Diagnostic Medical Research Services ,
Proteomics ,
Financial Performance ,
Share Price Movement Disruptions ,
Corporate Industrial News ,
Political General News ,
Health ,
Hepatitis ,
Medical Conditions ,
Infectious Diseases ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Synd ,
Akero Therapeutics ,
Makro ,
89bio ,
Getnb ,
Us00973y1082 ,
Us2825591033 ,
Share Price Movement ,
Disruptions ,
Corporate ,
Industrial News ,
Political ,
General News ,
Healthcare ,
Life Sciences ,
Business ,
Consumer Services ,
Diagnostic ,